TC BioPharm (Holdings) plc financial data

Symbol
TCBPY, TCBWF on OTC
Location
Maxim 1, 2 Parklands Way, Holytown, United Kingdom
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - May 9, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.99B shares
Common Stock, Shares, Outstanding 2.55B shares +12301%
Entity Public Float 3.1M USD
Common Stock, Value, Issued 255K GBP +12301%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +1369%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +1369%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.3M GBP -32.8%
General and Administrative Expense 2.14M GBP -3.98%
Operating Income (Loss) -3.44M GBP +17.4%
Nonoperating Income (Expense) 9.06K GBP -99.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.43M GBP -232%
Income Tax Expense (Benefit) -111K GBP +72.3%
Net Income (Loss) Attributable to Parent -3.32M GBP -423%
Earnings Per Share, Basic -0.11 GBP/shares +64.5%
Earnings Per Share, Diluted -0.11 GBP/shares +64.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.5M USD
Assets, Current 5.77M GBP +1.29%
Property, Plant and Equipment, Net 955K GBP -25.1%
Operating Lease, Right-of-Use Asset 1.13M GBP -15.5%
Intangible Assets, Net (Excluding Goodwill) 466K GBP -24.2%
Assets 8.33M GBP -6.75%
Accounts Payable, Current 942K GBP
Accrued Liabilities, Current 1.01M GBP -17.7%
Liabilities, Current 4.15M GBP -12.7%
Operating Lease, Liability, Noncurrent 1.17M GBP -21.7%
Liabilities 5.32M GBP -14.8%
Retained Earnings (Accumulated Deficit) -52.6M GBP -30.1%
Stockholders' Equity Attributable to Parent 3.8M USD
Liabilities and Equity 8.33M GBP -6.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.41M GBP +17.3%
Net Cash Provided by (Used in) Financing Activities 933K GBP -76.4%
Net Cash Provided by (Used in) Investing Activities -5.62K GBP +96.1%
Common Stock, Shares Authorized 2.55B shares +12301%
Common Stock, Shares, Issued 2.55B shares +12301%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.48M GBP -265%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.22M GBP -50.6%
Deferred Tax Assets, Valuation Allowance 6.27M GBP +40.8%
Deferred Tax Assets, Gross 6.27M GBP +40.8%
Operating Lease, Liability 1.5M GBP -16.7%
Depreciation 115K GBP -32.2%
Payments to Acquire Property, Plant, and Equipment 120K GBP
Property, Plant and Equipment, Gross 5.5M GBP +1.17%
Operating Lease, Liability, Current 328K GBP +7.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 447K GBP 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 447K GBP 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 434K GBP
Lessee, Operating Lease, Liability, to be Paid, Year Three 447K GBP 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 447K GBP 0%
Operating Lease, Payments 112K GBP 0%
Additional Paid in Capital 54.9M GBP +28.6%
Amortization of Intangible Assets 12.3K GBP +3.9%